Massachusetts-based Arch Therapeutics hopes to sell over 11 million shares to raise close to $3 million in support of its medical sealants and hemostasis products.
Arch Therapeutics launched a private placement fundraising effort, offering 11.4 million shares of common stock in hopes of raising $2.9 million.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1g1WQDB
Cap comentari:
Publica un comentari a l'entrada